These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15765311)

  • 21. Atazanavir: improving the HIV protease inhibitor class.
    Becker S
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):403-13. PubMed ID: 15482137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology, efficacy and safety of atazanavir: a review.
    Bentué-Ferrer D; Arvieux C; Tribut O; Ruffault A; Bellissant E
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1455-68. PubMed ID: 19863454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atazanavir.
    Orrick JJ; Steinhart CR
    Ann Pharmacother; 2004 Oct; 38(10):1664-74. PubMed ID: 15353575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of atazanavir in simplification regimens].
    Zamora L; Gatell JM
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():14-21. PubMed ID: 20116612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evidence-based therapeutic drug monitoring of atazanavir].
    Solas C; Muret P;
    Therapie; 2011; 66(3):213-9. PubMed ID: 21819805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adverse effects of atazanavir].
    Palacios R; González M; Ruiz J; Santos J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():41-4. PubMed ID: 20116616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of atazanavir: a novel HIV protease inhibitor.
    Fuster D; Clotet B
    Expert Opin Pharmacother; 2005 Aug; 6(9):1565-72. PubMed ID: 16086644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atazanavir: a novel HIV-1 protease inhibitor.
    Piliero PJ
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1295-301. PubMed ID: 12225250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of atazanavir in rescue therapy].
    Portilla J; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():22-7. PubMed ID: 20116613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacology, pharmacokinetic features and interactions of atazanavir].
    López-Cortés LF
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():2-8. PubMed ID: 20116610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipid profile of atazanavir].
    Martínez Chamorro E
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():34-40. PubMed ID: 20116615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical utility of atazanavir].
    Ribera Pascuet E; Curran A
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():55-67. PubMed ID: 20116619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV protease inhibitors: recent clinical trials and recommendations on use.
    Fernández-Montero JV; Barreiro P; Soriano V
    Expert Opin Pharmacother; 2009 Jul; 10(10):1615-29. PubMed ID: 19527188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Releasing the true power of protease inhibitors.
    Raffi F
    Int J STD AIDS; 2003 Oct; 14 Suppl 1():29-33. PubMed ID: 14617401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does atazanavir cause lipodystrophy?
    Gazzard BG; Moyle G
    J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atazanavir for the treatment of human immunodeficiency virus infection.
    Busti AJ; Hall RG; Margolis DM
    Pharmacotherapy; 2004 Dec; 24(12):1732-47. PubMed ID: 15585441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reviving protease inhibitors: new data and more options.
    Murphy RL
    J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S43-52; quiz S53, S55-6. PubMed ID: 12946064
    [No Abstract]   [Full Text] [Related]  

  • 38. The cellular pharmacokinetics of HIV protease inhibitors: current knowledge and future perspectives.
    Zha W; Zha BS; Zhou F; Zhou H; Wang G
    Curr Drug Metab; 2012 Oct; 13(8):1174-83. PubMed ID: 22746305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atazanavir: the advent of a new generation of more convenient protease inhibitors.
    Barreiro P; Rendón A; Rodríguez-Nóvoa S; Soriano V
    HIV Clin Trials; 2005; 6(1):50-61. PubMed ID: 15765311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atazanavir: a review of its use in the management of HIV-1 infection.
    Croom KF; Dhillon S; Keam SJ
    Drugs; 2009 May; 69(8):1107-40. PubMed ID: 19496633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.